Back
MoonLake Immunotherapeutics Stock Price Chart
10 Best Stocks to Own in 2025
Get your copy now FREE!
Sell
49
MLTX
MoonLake Immunotherapeutics
Last Price:
$39.05
Seasonality Move:
38.96%
7 Day Trial
ALL ACCESS PASS
$
7
10 stocks to buy for the next leg of this rally
Get the full list here FREE-
The current trend is relatively stagnant and MLTX is experiencing slight buying pressure.
MoonLake Immunotherapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 38.87 | Buy |
| 20-day SMA: | 39.02 | Sell |
| 50-day SMA: | 38.59 | Buy |
| 200-day SMA: | 45.74 | Sell |
| 8-day EMA: | 38.77 | Buy |
| 20-day EMA: | 38.85 | Buy |
| 50-day EMA: | 39.37 | Sell |
| 200-day EMA: | 43.44 | Sell |
MoonLake Immunotherapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.08 | Sell |
| Relative Strength Index (14 RSI): | 50.58 | Buy |
| Chaikin Money Flow: | 87654 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (37.91 - 40.71) | Sell |
| Bollinger Bands (100): | (37.21 - 45.15) | Sell |
MoonLake Immunotherapeutics Technical Analysis
| May 16 | May 19 | May 20 | May 21 | May 22 | May 23 | May 27 | May 28 | May 29 | May 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 16 | 19 | 20 | 21 | 22 | 23 | 27 | 28 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for MoonLake Immunotherapeutics Stock
Is MoonLake Immunotherapeutics Stock a Buy?
-
MoonLake Immunotherapeutics share price is 39.01 while MLTX 8-day simple moving average is 38.87, which is a Buy signal.
-
The stock price of MLTX is 39.01 while MoonLake Immunotherapeutics 20-day SMA is 39.02, which makes it a Sell.
-
MoonLake Immunotherapeutics 50-day simple moving average is 38.59 while MLTX share price is 39.01, making it a Buy technically.
-
MLTX stock price is 39.01 and MoonLake Immunotherapeutics 200-day simple moving average is 45.74, creating a Sell signal.
MLTX Technical Analysis vs Fundamental Analysis
Sell
49
MoonLake Immunotherapeutics (MLTX)
is a Sell
Is MoonLake Immunotherapeutics a Buy or a Sell?
-
MoonLake Immunotherapeutics stock is rated a SellThe current MoonLake Immunotherapeutics [MLTX] share price is $39.01. The Score for MLTX is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
MoonLake Immunotherapeutics Stock Info
Market Cap:
2.5B
Price in USD:
39.01
Share Volume:
228.9K
MoonLake Immunotherapeutics 52-Week Range
52-Week High:
58.26
52-Week Low:
31.42
Sell
49
MoonLake Immunotherapeutics (MLTX)
is a Sell
MoonLake Immunotherapeutics Share Price Forecast
-
What is the MoonLake Immunotherapeutics stock price today?The MoonLake Immunotherapeutics stock price is 39.01 USD today.
-
Will MLTX stock go up or go down?MoonLake Immunotherapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is MoonLake Immunotherapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, MoonLake Immunotherapeutics is overvalued.
Is MoonLake Immunotherapeutics Stock a Buy?
-
MoonLake Immunotherapeutics share price is 39.01 while MLTX 8-day exponential moving average is 38.77, which is a Buy signal.
-
The stock price of MLTX is 39.01 while MoonLake Immunotherapeutics 20-day EMA is 38.85, which makes it a Buy.
-
MoonLake Immunotherapeutics 50-day exponential moving average is 39.37 while MLTX share price is 39.01, making it a Sell technically.
-
MLTX stock price is 39.01 and MoonLake Immunotherapeutics 200-day simple moving average is 43.44, creating a Sell signal.
Fundamental Analysis of MoonLake Immunotherapeutics
Is MoonLake Immunotherapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.33 per share, a decrease next quarter of $0.11 per share, a decrease this year of $1.24 per share, and a decrease next year of $0.58 per share.
Technical Analysis of MoonLake Immunotherapeutics
Should I short MoonLake Immunotherapeutics stock?
-
MLTX Moving Average Covergence Divergence (MACD) indicator is -0.08, suggesting MoonLake Immunotherapeutics is a Sell
-
MoonLake Immunotherapeutics Relative Strength Index (RSI) is 50.58, which suggest MoonLake Immunotherapeutics is overbought
-
The Bollinger Bands (25) for MoonLake Immunotherapeutics is (37.91 - 40.71), which suggest MoonLake Immunotherapeutics is a Sell
-
The Bollinger Bands (100) for MoonLake Immunotherapeutics is (37.21 - 45.15), which suggest MoonLake Immunotherapeutics is a Sell
* MoonLake Immunotherapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.